HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

UP 202-56

an adenosine analogue

Also Known As:

UP-202-56; beta-D-ribofuranuronamide, N-cyclopropyl-1-deoxy-1-(6((2-(1-(2,5-dimethylbenzyl)-5-met hylindol-3-yl)ethyl)-amino))-9H-purin-9-yl

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purine Nucleosides: 360
        Adenosine: 12431
        UP 202-56: 1
    - Indoles: 200
      - UP 202-56: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Purine Nucleosides: 360
    - Adenosine: 12431
      - UP 202-56: 1
  - Ribonucleosides: 49
    - Adenosine: 12431
      - UP 202-56: 1

Related Diseases

1.

04/01/1998 - "These results increase evidence for a role of adenosine in the modulation of nociceptive transmission and support the antinociceptive action of adenosine analogues, such as UP 202-56, in inflammatory pain processes."
04/01/1998 - "Our results demonstrate that UP 202-56 dose-dependently reduced the spinal c-Fos protein expression in carrageenan model of inflammatory pain. "

Related Drugs and Biologics

1.	Proto-Oncogene Proteins c-fos (FRAs)
2.	Carrageenan
3.	Adenosine (Adenocard)